Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-021993

Chief Operating Officer gave up 2,990 shares (to pay taxes)

  • Chief Operating Officer acquired 6,863 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cittadine Andrew · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-30 Exercise or conversion : show line 1 in the form +6,863 48,848 D
2025-06-30 Shares withheld for taxes : show line 2 in the form −2,990 $35.78 $106,982 45,858 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −6,863 43,001 D
Loading xslF345X05/rdgdoc.xml…